Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis
Authors
Keywords
Mycobacterium tuberculosis, Macrophages, Antibiotic resistance, Ion channels, Antibiotics, Isoniazid, Bromides, Chlorpromazine
Journal
PLoS One
Volume 11, Issue 2, Pages e0149326
Publisher
Public Library of Science (PLoS)
Online
2016-02-27
DOI
10.1371/journal.pone.0149326
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy
- (2015) Marco Pieroni et al. JOURNAL OF MEDICINAL CHEMISTRY
- A giant molecular proton pump: structure and mechanism of respiratory complex I
- (2015) Leonid A. Sazanov NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Exploring the potential of adjunct therapy in tuberculosis
- (2015) Geetha Vani Rayasam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis
- (2014) P. A. Black et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The ATP synthase inhibitor bedaquiline interferes with small-molecule efflux in Mycobacterium smegmatis
- (2014) Ping Lu et al. JOURNAL OF ANTIBIOTICS
- Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study
- (2014) E. Cambau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs
- (2014) Kristin N. Adams et al. JOURNAL OF INFECTIOUS DISEASES
- Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success
- (2014) Liam S. Redgrave et al. TRENDS IN MICROBIOLOGY
- Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy
- (2014) Gerjo J. de Knegt et al. TUBERCULOSIS
- Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
- (2013) Shashank Gupta et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
- (2012) Aurelia M. Schmalstieg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs
- (2012) Miguel Viveiros et al. Expert Review of Anti-Infective Therapy
- What really happens in the neutrophil phagosome?
- (2012) James K. Hurst FREE RADICAL BIOLOGY AND MEDICINE
- The chemotherapy of tuberculosis: past, present and future [State of the art]
- (2012) D. Mitchison et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Antitubercular pharmacodynamics of phenothiazines
- (2012) A. J. Warman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition
- (2012) J. Perdigao et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages
- (2012) H. Bruns et al. JOURNAL OF IMMUNOLOGY
- Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
- (2012) Diana Machado et al. PLoS One
- Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux
- (2011) Gail E. Louw et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
- (2011) Kristin N. Adams et al. CELL
- Efflux as a mechanism for drug resistance inMycobacterium tuberculosis: Table 1
- (2011) Pedro Eduardo Almeida da Silva et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Calcium Channel Blockers
- (2011) William J. Elliott et al. Journal of Clinical Hypertension
- Activity of Drug Combinations against Dormant Mycobacterium tuberculosis
- (2010) P. Filippini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
- (2009) G. E. Louw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation
- (2009) B. Springer et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Microarray Analysis of Efflux Pump Genes in Multidrug-Resistant Mycobacterium tuberculosis During Stress Induced by Common Anti-Tuberculous Drugs
- (2009) Anuj Kumar Gupta et al. Microbial Drug Resistance
- Voltage Gated Calcium Channels Negatively Regulate Protective Immunity to Mycobacterium tuberculosis
- (2009) Shashank Gupta et al. PLoS One
- A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis
- (2008) Omar H Vandal et al. NATURE MEDICINE
- The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
- (2008) S. P. S. Rao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search